Trial Profile
Prospective and genomics studies on precision Neo-adjuvant treatments in hypopharyngeal carcinoma patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Docetaxel (Primary) ; Lobaplatin (Primary)
- Indications Hypopharyngeal cancer
- Focus Therapeutic Use
- 28 Oct 2016 New trial record